Compare KRYS & R Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | R |
|---|---|---|
| Founded | 2015 | 1933 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Rental/Leasing Companies |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.6B |
| IPO Year | 2017 | 1994 |
| Metric | KRYS | R |
|---|---|---|
| Price | $347.00 | $243.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 10 |
| Target Price | ★ $297.60 | $238.56 |
| AVG Volume (30 Days) | 200.3K | ★ 209.5K |
| Earning Date | 05-04-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.48% |
| EPS Growth | ★ 128.00 | 7.96 |
| EPS | 3.62 | ★ 5.71 |
| Revenue | $389,130,000.00 | ★ $12,665,000,000.00 |
| Revenue This Year | $38.74 | $5.00 |
| Revenue Next Year | $32.53 | $5.05 |
| P/E Ratio | $96.16 | ★ $42.86 |
| Revenue Growth | ★ 33.94 | 0.23 |
| 52 Week Low | $145.46 | $157.77 |
| 52 Week High | $382.54 | $284.25 |
| Indicator | KRYS | R |
|---|---|---|
| Relative Strength Index (RSI) | 48.23 | 35.46 |
| Support Level | $289.36 | $241.36 |
| Resistance Level | $382.33 | $268.38 |
| Average True Range (ATR) | 11.24 | 4.75 |
| MACD | -0.73 | -0.03 |
| Stochastic Oscillator | 28.36 | 9.49 |
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Ryder System Inc operates in three business segments: (1) Fleet Management Solutions which provides full-service leasing and leasing with flexible maintenance options, commercial rental and maintenance services of trucks, tractors and trailers to customers; (2) Supply Chain Solutions (SCS), which provides integrated logistics solutions, including distribution management, dedicated transportation, transportation management, brokerage, e-commerce, last mile, and professional services; and (3) Dedicated Transportation Solutions (DTS), which provides turnkey transportation solutions in the U.S., including dedicated vehicles, professional drivers, management, and administrative support.